Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basolateral potassium (K+) channels in the intestinal epithelium are critical regulators of transepithelial ion and water transport. These channels, primarily the intermediate-conductance calcium-activated potassium channel (KCNN4, also known as KCa3.1 or IK1) and the voltage-gated potassium channel (KCNQ1, often associated with the KCNE3 subunit), are localized to the basolateral membrane of enterocytes and crypt cells [1.1.1, 1.3.4]. Their primary function is to facilitate K+ efflux, which maintains a negative (hyperpolarized) membrane potential and recycles K+ ions taken up by the Na+/K+-ATPase and NKCC1 transporters [1.1.3, 1.2.3]. This hyperpolarization provides the essential electrochemical driving force for apical chloride (Cl-) secretion through channels like the cystic fibrosis transmembrane conductance regulator (CFTR) [1.1.4, 1.3.2]. In pathological states such as secretory diarrhea (e.g., cholera or diarrhea induced by tyrosine kinase inhibitors like afatinib), these channels are overactivated, leading to excessive fluid secretion [1.4.1]. Conversely, their expression is often downregulated in inflammatory bowel diseases (IBD), contributing to electrolyte imbalances [1.2.1]. Pharmacological inhibition of these channels with agents such as senicapoc or clotrimazole is being explored as a therapeutic strategy to reduce intestinal fluid loss [1.4.1, 1.3.5].
Inhibition of basolateral potassium channels reduces the hyperpolarization of the epithelial cell membrane, thereby decreasing the electrical driving force for apical chloride secretion and subsequent water loss in secretory diarrhea.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basolateral potassium channels in intestinal epithelium.